Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Mammalian diaphanous-related formin 1 is required for motility and invadopodia formation in human U87 glioblastoma cells.
|
24317603 |
2014 |
Allergic Reaction
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology.
|
29083406 |
2017 |
Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our findings localize DIAPH1 particularly to myeloid cells in the CNS, especially in AD in the locations of lipid droplet accumulation, thereby implicating RAGE-DIAPH1 signaling in dysregulated lipid metabolism and morphological changes of inflamed myeloid cells in this disorder.
|
29966194 |
2018 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Bronchiectasis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Recently, however, a homozygous nonsense DIAPH1 mutation (c.2332C4T; p.Q778X) was reported in five siblings in a single family affected by microcephaly, blindness, early onset seizures, developmental delay, and bronchiectasis.
|
26463574 |
2016 |
Central visual impairment
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Mammalian diaphanous-related formin 1 is required for motility and invadopodia formation in human U87 glioblastoma cells.
|
24317603 |
2014 |
Childhood onset
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Colon Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Thus, blockade of DIAPH1-tubulin interaction may be a promising approach to inhibit one of the earliest steps in the metastatic cascade of colon cancer.
|
26124177 |
2015 |
Colon Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
This very strong reducing effect of DIAPH1 depletion on colon carcinoma cell metastasis makes the protein a promising therapeutic target for individualized colorectal cancer therapy.
|
24105619 |
2014 |
Colorectal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
As well as cortactin, DIAPH1 was not detectable in normal colon tissue and expression of both proteins was positively correlated with metastasis of colorectal cancer.
|
24105619 |
2014 |
Coronary Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The Formin, DIAPH1, is a Key Modulator of Myocardial Ischemia/Reperfusion Injury.
|
29239839 |
2017 |
Cortical visual impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
Biomarker
|
disease |
CLINGEN |
cAMP-stimulated phosphorylation of diaphanous 1 regulates protein stability and interaction with binding partners in adrenocortical cells.
|
23325789 |
2013 |
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
Biomarker
|
disease |
CLINGEN |
Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous.
|
9360932 |
1997 |
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
GermlineCausalMutation
|
disease |
ORPHANET |
A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.
|
26912466 |
2016 |
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Constitutive activation of DIA1 (DIAPH1) via C-terminal truncation causes human sensorineural hearing loss.
|
27707755 |
2016 |
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
GermlineCausalMutation
|
disease |
ORPHANET |
Extension of the clinical and molecular phenotype of DIAPH1-associated autosomal dominant hearing loss (DFNA1).
|
27808407 |
2017 |
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
Biomarker
|
disease |
CTD_human |
|
|
|
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
GeneticVariation
|
disease |
UNIPROT |
Extension of the clinical and molecular phenotype of DIAPH1-associated autosomal dominant hearing loss (DFNA1).
|
27808407 |
2017 |
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
Biomarker
|
disease |
CLINGEN |
A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.
|
26912466 |
2016 |
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
Biomarker
|
disease |
CLINGEN |
Extension of the clinical and molecular phenotype of DIAPH1-associated autosomal dominant hearing loss (DFNA1).
|
27808407 |
2017 |
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
GeneticVariation
|
disease |
UNIPROT |
Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous.
|
9360932 |
1997 |
DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)
|
0.610 |
Biomarker
|
disease |
CLINGEN |
Constitutive activation of DIA1 (DIAPH1) via C-terminal truncation causes human sensorineural hearing loss.
|
27707755 |
2016 |